Medical/Pharmaceuticals
Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2021
HONG KONG, Sept. 17, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 20...
2021-09-17 19:00
19286
Terumo Celebrates 100th Anniversary of Contributing to Society Through Healthcare
TOKYO, Sept. 17, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543), a global leader in medical technology, today celebrates its 100th anniversary. The company, based inTokyo, boasts over 25,000 associates worldwide, providing products and services to more than 160 countries and regions across...
2021-09-17 15:30
3979
Vieworks to Showcase its Complete Dental Detector Lineup at IDS 2021
ANYANG, South Korea, Sept. 17, 2021 /PRNewswire/ -- Vieworks, a global leader in the X-ray imaging industry, presents its complete dental detector lineups at the International Dental Show (IDS) 2021 (hall 11.2 P/R 28/29) from 22 to 25 September. IDS is the world's biggest trade fair for dentistry...
2021-09-17 15:00
2916
BioVaxys Cancer Vaccine Manufacturing Partner Bio Elpida Reaches Bioproduction Milestone
VANCOUVER, British Columbia, Sept. 17, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys"), announced today that cancer vaccine manufacturing partner Bio Elpida inLyon, France, has reached major milestones in the development of the bioproduction proce...
2021-09-17 15:00
6454
CStone will present registrational clinical study data of Sugemalimab in patients with stage III non-small cell lung cancer in an oral presentation at ESMO Congress 2021
* Sugemalimab is the world's first anti-PD-1/PD-L1 monoclonal antibody to significantly improve progression-free survival (PFS) in patients withstage III non-small cell lung cancer (NSCLC) without disease progression after concurrent or sequential chemoradiotherapy * The data showed that suge...
2021-09-17 08:00
4509
Innovent Releases Phase 2 Results of Pemigatinib in Chinese Patients with Advanced Cholangiocarcinoma at ESMO Congress 2021
SAN FRANCISCO and SUZHOU, China, Sept. 17, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...
2021-09-17 08:00
7031
Everest Medicines, Sinovent and SinoMab Announce Licensing Agreement for Global Development, Manufacturing and Commercialization of Novel BTK Inhibitor in Renal Diseases
SHANGHAI, Sept. 17, 2021 /PRNewswire/ -- Everest Medicines
2021-09-17 06:30
6981
PharmaZell and Novasep enter into exclusive negotiations in new drive to create a technology-driven leader for complex small molecules and ADCs of global scale
RAUBLING, Germany and LYON, France, Sept. 17, 2021 /PRNewswire/ -- PharmaZell, the German producer of highly resilient and specialty APIs, andFrance-based Novasep, a leading CDMO focused on complex small molecules and ADCs have entered into exclusive negotiations to create a leading European plat...
2021-09-17 03:59
3453
Satisfai Health acquires global license for AI software to detect early cancer in Barrett's Esophagus
Advanced real-time clinical diagnostics for up to 150 million people VANCOUVER, BC, Sept. 16, 2021 /PRNewswire/ -- Satisfai Health, a leading medical solutions provider specializing in artificial intelligence (AI) applications, particularly in Gastrointestinal Endoscopy, has acquired an exclusiv...
2021-09-16 22:17
4054
Validic Empowers Physicians and Care Managers to Manage Personal Health Data at Scale
Validic's best-in-class strategy is supported by its deep integration into clinical workflows and care pathways and its simple application design for consumer engagement SANTA CLARA, Calif., Sept. 16, 2021 /PRNewswire/ -- Based on its recent analysis of the North American remote patient monitori...
2021-09-16 21:00
2562
Beyond Ventures' first investment, Prenetics, becomes first Hong Kong unicorn to go public
HONG KONG, Sept. 16, 2021 /PRNewswire/ -- Hong Kong-based venture capital firm Beyond Ventures is pleased to support today's announcement by the firm's first investee company, Prenetics, that Prenetics, a global leader in genomic and diagnostic testing is set to merge with Artisan Acquisition Cor...
2021-09-16 15:31
2821
SuperTrans Medical supported by U.S. National Institutes of Health (NIH) in developing its lead antibiotic against urgent threat drug resistant bacteria
SYDNEY, Sept. 16, 2021 /PRNewswire/ -- SuperTrans Medical ("STM"), a biopharmaceutical company developing novel antibiotics that target difficult-to-treat, multi-drug resistant bacterial infections, has announced that the U.S. National Institutes of Health (NIH) will be supporting additional dev...
2021-09-16 08:45
3849
Charles Bodner Joins CSafe Global as Chief Financial Officer
CSafe Global has hired Charles Bodner as CFO following Patrick Schafer's promotion to CEO in 2020. DAYTON, Ohio, Sept. 16, 2021 /PRNewswire/ -- CSafe Global, the innovation leader in temperature-controlled solutions for the pharmaceutical industry, announced today that Charles ('Chuck') Bodner h...
2021-09-16 06:25
5782
Prenetics, a Global Leader in Genomic and Diagnostic Testing, to Become Publicly Traded on the Nasdaq via Merger with Adrian Cheng's Artisan Acquisition Corp.
* Prenetics' mission is to disrupt and decentralise the healthcare industry with a global opportunity of overUS$1.3 trillion. * Prenetics' multi-product healthcare ecosystem strategy is driven by prevention focused genomic testing, rapid diagnostics for COVID-19 and infectious diseases, and c...
2021-09-16 06:00
8740
ThinkSono DVT detection software results are published in Nature digital medicine (npj)
LONDON and POTSDAM, Germany, Sept. 15, 2021 /PRNewswire/ -- A team of researchers are developing the use of an artificial intelligence (AI) algorithm with the aim of diagnosing deep vein thrombosis (DVT) more quickly and as effectively as traditional radiologist-interpreted diagnostic scans, pot...
2021-09-15 19:34
3656
2021 Centre for Medicines Research (CMR) Pharmaceutical R&D Factbook from Clarivate Finds Drug Approvals at a 10-year High Despite the Challenges of COVID-19
LONDON, Sept. 15, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of the2021 Centre for Medicines Research (CMR) International Pharmaceutical R&D Factbook. The 2021 CMR ...
2021-09-15 16:00
1654
Sputnik V Demonstrates 97.2% Efficacy And High Safety Profile Against COVID During The Vaccination Campaign In Belarus
MOSCOW, Sept. 15, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the real world data of the Ministry of Health of theRepublic of Belarus on the Russian Sputnik V coronavirus vaccine confirming its high efficacy during the vaccination campai...
2021-09-15 16:00
1942
CStone received China NMPA IND approval for CS2006/NM21-1480, a PD-L1/4-1BB/HSA multi-specific antibody, marking further expansion of its Pipeline 2.0
SUZHOU, China, Sept. 15, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that the investigational ne...
2021-09-15 08:30
3851
PolyU develops groundbreaking and highly effective targeted osteoarthritis pain reliever
HONG KONG, Sept. 14, 2021 /PRNewswire/ -- Researchers at The Hong Kong Polytechnic University (PolyU) have developed a groundbreaking, imaging-guided nanoparticle photothermal treatment for osteoarthritis pain, utilising the concept of targeted cancer therapy but instead applied to the protein th...
2021-09-14 20:37
2532
BioVaxys Bioproduction Partner WuXi Biologics Completes Synthesis Of Recombinant SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH Programs
VANCOUVER, BC, Sept. 14, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys"), announced today that global CDMO partner WuXi Biologics, has completed the synthesis of recombinant SARS-CoV-2 s-protein for BVX-0320, the company's COVID-19 vaccine candida...
2021-09-14 15:00
6517
Week's Top Stories
Most Reposted
Mastercard elevates premium travel with Asia Pacific's first Taste by Priceless dining club at Hong Kong International Airport
[Picked up by 325 media titles]
2026-08-05 11:34
MetaOptics Sharpens Focus on Metalens Commercialisation; Withdraws Nasdaq Listing Application, and Defers U.S. Dual Listing Plan
[Picked up by 307 media titles]
2026-08-07 22:30Thailand Ready to Welcome 191 Countries to the 2026 Annual Meetings of the International Monetary Fund and the World Bank Group
[Picked up by 296 media titles]
2026-08-06 15:10
Hyatt Regency Kuala Lumpur At KL Midtown: A Refined Urban Retreat Recognised For Design Excellence
[Picked up by 296 media titles]
2026-08-04 07:00
Vitafoods Asia Announces Strategic Move to Kuala Lumpur for 2027 Edition
[Picked up by 292 media titles]
2026-08-04 14:30
Most Read
Hyatt Regency Kuala Lumpur At KL Midtown: A Refined Urban Retreat Recognised For Design Excellence
2026-08-04 07:00
10971
Mastercard elevates premium travel with Asia Pacific's first Taste by Priceless dining club at Hong Kong International Airport
2026-08-05 11:34
8648
Singapore Good Soil Foundation Hosts Third Next Generation Philanthropy Leadership Program at the University of Hong Kong, Empowering the Next Generation of Global Changemakers
2026-08-02 02:09
8071
Gene Solutions Advances Precision Oncology Education in Malaysia with the ''Beyond Actionable'' Academy
2026-08-04 06:00
7452
Vitafoods Asia Announces Strategic Move to Kuala Lumpur for 2027 Edition
2026-08-04 14:30
7114